AMPA receptor binding in the dorsolateral prefrontal cortex of schizophrenics and controls [1]

Schizophrenia Research

Volumn 48, Issue 2-3, 2001, Pages 361-363

  Noga, J Thomas ^a,c   Hyde, Thomas M ^b   Bachus, Susan E ^b   Herman, Mary M ^b   Kleinman, Joel E ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; NEUROLEPTIC AGENT;

BRAIN REGION; DOPAMINE RELEASE; HUMAN; LETTER; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; SCHIZOPHRENIA; SUICIDE;

EID: 0035970636     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00121-3     Document Type: Article

References (9)

1. Effects of a memory enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-isoxazole-propionic acid receptor currents and synaptic transmission in hippocampus
2. A preliminary dose escalation trial of CX516 (ampakine) added to clozapine in schizophrenia
3. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics
4. Glutamatergic control of dopamine release during stress in the rat prefrontal cortex
5. Synergistic interactions between ampakines and antipsychotic drugs
6. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors modulate dopamine release in rat hippocampus and striatum
7. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains
8. Effects of pharmacologically stimulating glutamatergic transmission in the trisynaptic intrahippocampal circuit
9. Facilitation of glutamate receptors enhances memory